COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2

Lee, Jian-Jr; Chen, Chia-Hua; Chen, Ya-Hsin; Huang, Miao-Juei; Huang, John; Hung, Ji-Shiang; Chen, Ming-Ting; Huang, Min-Chuan
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Infantile hemangiomas are localized lesions comprised primarily of aberrant endothelial cells. COSMC plays a crucial role in blood vessel formation and is characterized as a molecular chaperone of T-synthase which catalyzes the synthesis of T antigen (Galβ1,3GalNAc). T antigen expression is associated with tumor malignancy in many cancers. However, roles of COSMC in infantile hemangioma are still unclear. In this study, immunohistochemistry showed that COSMC was upregulated in proliferating hemangiomas compared with involuted hemangiomas. Higher levels of T antigen expression were also observed in the proliferating hemangioma. Overexpression of COSMC significantly enhanced cell growth and phosphorylation of AKT and ERK in human umbilical vein endothelial cells (HUVECs). Conversely, knockdown of COSMC with siRNA inhibited endothelial cell growth. Mechanistic investigation showed that O-glycans were present on VEGFR2 and these structures were modulated by COSMC. Furthermore, VEGFR2 degradation was delayed by COSMC overexpression and facilitated by COSMC knockdown. We also showed that COSMC was able to regulate VEGF-triggered phosphorylation of VEGFR2. Our results suggest that COSMC is a novel regulator for VEGFR2 signaling in endothelial cells and dysregulation of COSMC expression may contribute to the pathogenesis of hemangioma.


Related Articles

  • Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings. Bieche, Ivan; Vacher, Sophie; Vallerand, David; Richon, Sophie; Hatem, Rana; De Plater, Ludmilla; Dahmani, Ahmed; Némati, Fariba; Angevin, Eric; Marangoni, Elisabetta; Roman-Roman, Sergio; Decaudin, Didier; Dangles-Marie, Virginie // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background: Tumor endothelial transdifferentiation and VEGFR1/2 expression by cancer cells have been reported in glioblastoma but remain poorly documented for many other cancer types. Methods: To characterize vasculature of patient-derived tumor xenografts (PDXs), largely used in preclinical...

  • Inducement of mitogen-activated protein kinases in frozen shoulders. Katsuaki Kanbe; Kazuhiko Inoue; Yasuo Inoue; Qian Chen // Journal of Orthopaedic Science;Jan2009, Vol. 14 Issue 1, p56 

    Abstract Background  Mitogen-activated protein (MAP) kinases are well-known molecules that play key roles in mechanical stress signals during skeletal development. To test our hypothesis that the synovium in frozen shoulders is induced by MAP kinases, immunohistochemical analyses for...

  • Expression of vascular endothelial growth factor C in human pterygium. Fukuhara, Junichi; Kase, Satoru; Ohashi, Tsutomu; Ando, Ryo; Dong, Zhenyu; Noda, Kousuke; Ohguchi, Takeshi; Kanda, Atsuhiro; Ishida, Susumu // Histochemistry & Cell Biology;Feb2013, Vol. 139 Issue 2, p381 

    Vascular endothelial growth factor C (VEGF-C) and its receptor VEGFR-3 mediate lymphangiogenesis. In this study, we analyzed the expression of VEGF-C and VEGFR-3 as well as lymphatic vessels in the pterygium and normal conjunctiva of humans. Fifteen primary nasal pterygia and three normal bulbar...

  • Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma. Gershtein, E.; Dubova, E.; Shchegolev, A.; Kushkinskii, N. // Bulletin of Experimental Biology & Medicine;Jun2010, Vol. 149 Issue 6, p749 

    Histological analysis demonstrated an increase in the number of blood vessels and expression of CD34 and vascular endothelial growth factor in hepatocellular carcinoma tissue compared to adjacent liver tissue. Increased immunohistochemical expression of vascular endothelial growth factor and the...

  • D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Debelenko, Larisa V.; Perez-Atayde, Antonio R.; Mulliken, John B.; Liang, Marilyn G.; Archibald, Tonora H.; Kozakewich, Harry P. W. // Modern Pathology;Nov2005, Vol. 18 Issue 11, p1454 

    Kaposiform hemangioendothelioma is a distinctive vascular neoplasm affecting predominantly children and neonates. In neonates it needs to be differentiated from common infantile hemangioma and other vascular lesions of infancy. Kaposiform hemangioendothelioma immunoreacts with vascular...

  • Are epsins a therapeutic target for tumor angiogenesis? Klauber-DeMore, Nancy // Journal of Clinical Investigation;Dec2012, Vol. 122 Issue 12, p17 

    Solid tumor growth requires the formation of new blood vessels to supply nutrients and oxygen to the malignant cells; one approach to cancer therapy is to block this process by inhibiting VEGF signaling. In this issue of the JCI, Pasula et al. demonstrate a surprising role of epsins -- proteins...

  • Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Carbajo-Pescador, S; Ordoñez, R; Benet, M; Jover, R; García-Palomo, A; Mauriz, J L; González-Gallego, J // British Journal of Cancer;7/9/2013, Vol. 109 Issue 1, p83 

    Background:Hepatocellular carcinoma (HCC) growth relies on angiogenesis via vascular endothelial growth factor (VEGF) release. Hypoxia within tumour environment leads to intracellular stabilisation of hypoxia inducible factor 1 alpha (Hif1α) and signal transducer and activator of...

  • The Growth and Aggressive Behavior of Human Osteosarcoma Is Regulated by a CaMKII-Controlled Autocrine VEGF Signaling Mechanism. Daft, Paul G.; Yang, Yang; Napierala, Dobrawa; Zayzafoon, Majd // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Osteosarcoma (OS) is a hyperproliferative malignant tumor that requires a high vascular density to maintain its large volume. Vascular Endothelial Growth Factor (VEGF) plays a crucial role in angiogenesis and acts as a paracrine and autocrine agent affecting both endothelial and tumor cells. The...

  • T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells. Bhattacharya, Debanjan; Singh, Manoj; Chaudhuri, Suhnrita; Acharya, Sagar; Basu, Anjan; Chaudhuri, Swapna // Journal of Neuro-Oncology;Jun2013, Vol. 113 Issue 1, p13 

    The crucial role of angiogenesis in malignant glioma progression makes it a potential target of therapeutic intervention in glioma. Previous studies from our lab showed that sheep erythrocyte membrane glycopeptide T11-target structure (T11TS) has potent anti-neoplastic and immune stimulatory...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics